Patent 10583110 - Antitumoral use of cabazitaxel > Summary
US Patent
Patent Application No. US 10583110
Published on Mar 10, 2020
Application No. 15/627962
Field on Jun 20, 2017
Classification
International:
A61K 31/337
A61K 31/164;
A61K 31/56;
A61K 31/573;
A61K 45/06;
A61K 38/19;